title: Gonorrhoea surveillance, laboratory diagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae in 11 countries of the eastern part of the WHO European region.
abstract: Quality-assured worldwide surveillance of antimicrobial resistance (AMR) in Neisseria gonorrhoeae is crucial for public health purposes. In the countries of the eastern part of the WHO European region the knowledge regarding gonococcal AMR is limited, and antimicrobials of many different types, sources and quality are used for gonorrhoea treatment. This study surveyed gonorrhoea incidence, laboratory diagnosis and gonococcal AMR testing in 11 independent countries of the former Soviet Union. The national gonorrhoea incidences remain mainly high. In general, gonococcal culture and AMR testing were rarely performed, poorly standardized and rarely quality assured. To establish a gonococcal AMR surveillance programme in Eastern Europe, i.e. the geographical area of the former Soviet Union, several actions have recently been undertaken by the Eastern European Sexual and Reproductive Health (EE SRH) Network and the WHO. The information provided herein will be useful in this respect.
authors.affiliation: National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden.
authors.forename: Magnus
authors.initials: M
authors.lastname: Unemo
authors.affiliation: Laboratory of Microbiology, the DO Ott Research Institute of Obstetrics and Gynecology, St. Petersburg, Russia.
authors.forename: Elena
authors.initials: E
authors.lastname: Shipitsyna
authors.affiliation: Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
authors.forename: Marius
authors.initials: M
authors.lastname: Domeika
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019411:Clinical Laboratory Techniques; D024881:Drug Resistance, Bacterial; D005061:Europe, Eastern / Q000453:epidemiology; D006069:Gonorrhea / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects* / Q000254:growth & development; D011159:Population Surveillance / Q000379:methods; D011634:Public Health; D011795:Surveys and Questionnaires; D014944:World Health Organization
chemical_list: D000900:Anti-Bacterial Agents